← Back to directory
YC
Ysios Capital
Barcelona, SpainWebsite ↗
Ysios Capital is a leading European venture capital firm focused on life sciences, providing private equity financing to early- and mid-stage biotech companies that develop novel therapeutic drugs for high unmet medical needs. The firm is dedicated to supporting pioneering science and exceptional teams to bring life-changing treatments to patients.
Last raised
Mar 2026
4 mo ago
Latest fund size
$107M
InceptionBio
AUM
$420M
estimated
Funds raised
Capital this firm has raised, newest first
InceptionBio
Mar 2026
$107M
Ysios BioFund III
May 2021 · YBF III
$231.1M
Ysios BioFund II Innvierte
Oct 2016
$135.2M
Ysios BioFund I
Jan 2008
$69.5M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Sanifit | — | — | Unknown | |
| Aura Biosciences | — | — | Unknown | |
| Prexton Therapeutics | — | — | Unknown | |
| Adcendo | — | — | Unknown | |
| SpliceBio | — | — | Unknown | |
| Minoryx Therapeutics | — | — | Unknown | |
| ONA Therapeutics | — | — | Jun 2026 | |
| Anaconda Biomed | — | — | Jan 2025 |
Sources
Where this data came from